16-502

People with mild or moderate asthma

16-502, £4000 – £4,060
+reasonable travel expenses

People with mild or moderate asthma who use only a short acting reliever inhaler needed for the study of a potential new treatment for severe asthma. You must be at least 21 years old and, if you’re a woman, you must be postmenopausal, sterilised or have an IUD fitted. The trial involves 2 screening visits, 5 sessions of 2 nights’ residence, 2 outpatient visits and 1 night’s residence. Starts 16 March 2022.